Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Malignant Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01557114
What this trial is testing

Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma

Who this might be right for
Malignant Melanoma
Gustave Roussy, Cancer Campus, Grand Paris 19
Early research (Phase 1)Study completedNCT00470015
What this trial is testing

Vaccine Therapy and GM-CSF With or Without Low-Dose Aldesleukin in Treating Patients With Stage II, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Mayo Clinic 20
Testing effectiveness (Phase 2)Ended earlyNCT05234437
What this trial is testing

A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma

Who this might be right for
Melanoma
QBiotics Group Limited 1
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Large-scale testing (Phase 3)Study completedNCT01866319
What this trial is testing

Study to Evaluate the Safety and Efficacy of Two Different Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Participants With Advanced Melanoma (MK-3475-006/KEYNOTE-006)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 834
Large-scale testing (Phase 3)Looking for participantsNCT05522660
What this trial is testing

Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerMelanoma
ETOP IBCSG Partners Foundation 180
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Not applicableStudy completedNCT03199846
What this trial is testing

Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States

Who this might be right for
Melanoma
Bristol-Myers Squibb 650
Early research (Phase 1)Study completedNCT00089362
What this trial is testing

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more
National Cancer Institute (NCI) 30
Not applicableLooking for participantsNCT04513028
What this trial is testing

Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Kelly McMasters 30
Large-scale testing (Phase 3)Looking for participantsNCT06519266
What this trial is testing

PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver Metastases

Who this might be right for
Uveal MelanomaLiver Metastases
Vastra Gotaland Region 40
Large-scale testing (Phase 3)Study completedNCT00324155
What this trial is testing

Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 681
Testing effectiveness (Phase 2)WithdrawnNCT02812693
What this trial is testing

Pembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/Amplification

Who this might be right for
Stage IIIA Skin MelanomaStage IIIB Skin MelanomaStage IIIC Skin Melanoma+1 more
Joanne Jeter
Early research (Phase 1)Study completedNCT01239134
What this trial is testing

Trial of TRX518 (Anti-GITR mAb) in Stage III or IV Malignant Melanoma or Other Solid Tumors

Who this might be right for
Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies
Leap Therapeutics, Inc. 10
Early research (Phase 1)Study completedNCT03064763
What this trial is testing

Study to Evaluate the Safety/ Efficacy of T-VEC in Japanese Subjects With Unresectable Stage IIIB-IV Malignant Melanoma

Who this might be right for
Unresectable Stage IIIB-IV Malignant Melanoma
Amgen 18
Not applicableUnknownNCT05445752
What this trial is testing

Conservative Nodal Surgery (Node-picking) of Patients With Stage III Melanoma With Low-burden of Nodal Disease (MELCONSURG MULTICENTRE COHORT)

Who this might be right for
Melanoma Stage III
Hospital Universitario Virgen Macarena 68
Early research (Phase 1)Active Not RecruitingNCT03769155
What this trial is testing

VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma

Who this might be right for
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8Pathologic Stage IIID Cutaneous Melanoma AJCC v8
Emory University 41
Not applicableStudy completedNCT02129049
What this trial is testing

Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children

Who this might be right for
Breast CancerCervical CancerColon Cancer+5 more
University of Washington 35
Early research (Phase 1)Study completedNCT00142454
What this trial is testing

NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)

Who this might be right for
Malignant Melanoma
Ludwig Institute for Cancer Research 9
Not applicableStudy completedNCT05079113
What this trial is testing

Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting

Who this might be right for
Stage III MelanomaStage IV Cutaneous Melanoma
Case Comprehensive Cancer Center 73
Next Page